ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

DELIVERING ON THE PROMISES OF INTRANASAL VACCINATION

Aptar Pharma's Julie Suman and Nektaria Karavas review intranasal delivery as a method of vaccine administration and consider the challenges and benefits of intranasal delivery.

WAITING FOR THE OUTBREATH – WHAT CAN COVID-19 BIOAEROSOL RESEARCH TELL US ABOUT INHALABLE DRUG DELIVERY?

Deborah Norris, Mark Allen, Karl Hewson and Karla Sanchez, discuss how the covid-19 pandemic has spurred research in the pulmonary space, which suggests that a patient-tailored approach based on their individual lung characteristics, facilitated by advanced technology, could improve patient health outcomes and quality of life.

DELIVERING SUSPENSIONS WITH MESH TECHNOLOGY

Edgar Hernan Cuevas Brun and Yuan-Ming Hsu discuss the performance of mesh nebulisers for the delivery of suspensions in inhalation therapy.

CHARACTERISING WALL THICKNESS OF QUALI-V<sup>®</sup>-I CAPSULES & ITS EFFECT ON CAPSULE PUNCTURE BY A DPI PIN

CHARACTERISING WALL THICKNESS OF QUALI-V^®-I CAPSULES & ITS EFFECT ON CAPSULE PUNCTURE BY A DPI PIN

Siamac Parker, Sion Coulman, Prof James Birchall alongside Susana Ecenarro and Mahmoud Farag, present a study that uses optical coherence tomography to characterise the wall thickness of capsules at the dome position and investigates the importance of controlling the dome thickness of hard-shell capsules to be used in a dry powder inhaler.

ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY

ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY

Robert Lee discusses the benefits of administering drugs to the nasal cavity, as well as the main challenges in formulation for this route and the strategies that can be applied to overcome them.

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis looks at the factors that should be considered when designing devices with a view to sustainable connectivity.

POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY

POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY

Jamie Clayton, Joana Pinto and Sarah Zellnitz discuss the benefits of multi-faceted powder characterisation in dry powder inhalation formulations and how it can support efforts to achieve net zero emissions.

LEVERAGING HUMAN FACTORS TO DEVELOP PATIENT-CENTRIC INHALERS

Raphaële Audibert

LEVERAGING HUMAN FACTORS TO DEVELOP PATIENT-CENTRIC INHALERS

Raphaële Audibert, Mark Tunkel and Manuela Basso look at the role patient-centricity has to play in the development of inhalers to treat chronic respiratory diseases.

NUMERICAL SIMULATIONS FOR INHALATION PRODUCT DEVELOPMENT: ACHIEVEMENTS AND CURRENT LIMITATIONS

Dr Andrea Benassi

NUMERICAL SIMULATIONS FOR INHALATION PRODUCT DEVELOPMENT: ACHIEVEMENTS AND CURRENT LIMITATIONS

Andrea Benassi and Ciro Cottini discuss the current state of CFD and DEM computational modelling, how it is used to improve inhaler design and manufacturing, and what the current limitations of this technology are, as well as how those limitations may be overcome.

IMPROVING IN VITRO TEST METHODS FOR NASAL DRUG PRODUCTS

Copley Scientific

IMPROVING IN VITRO TEST METHODS FOR NASAL DRUG PRODUCTS

Mark Copley and Anna Sipitanou look at how in vitro testing is being refined for greater repeatability to maximise its value as a low-cost tool for product development, including an assessment of the role of automation in improving the sensitivity of in vitro testing.

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

Howard Burnett, Chris Baron and Jay Bhogaita summarise the findings of a recent forum that looked at the development of more sustainable pressurised metered dose inhalers.

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.

TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING

TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING

Bas van Driel discusses how expert collaborations can help develop a knowledge base to transform drug delivery and manufacturing. He shares how recent collaborative research projects involving lactose-based dry powder inhalation formulations, with and without magnesium stearate and lactose as an excipient in 3D tablet printing, have done just that.

Respiratory Drug Delivery (RDD<sup>®</sup> 2022)

1st May 2022 - 5th May 2022

Orlando, FL, USA

Respiratory Drug Delivery (RDD^® 2022)

RDD^® 2022 will be in-person at the Omni Orlando Champions Gate, Orlando, FL, US, and will include: Knowledge Spaces; Prominent researchers & key opinion leaders; Explore with Experts discussion sessions; Posters; Workshops; Exhibit tables; Networking events; The Charles G. Thiel and RDD VCU Peter R. Byron Graduate Student awards; and Peer-reviewed electronic proceedings.

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner

Alliance to Zero

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Kindeva Drug Delivery

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Louise Righton busts six sustainability myths about inhalers.

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

Peter Soelkner and Thomas Otto discuss how the pharmaceutical service provider focuses on sustainability.

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green discusses how H&T Presspart’s plasma treatment process can provide a future-proof and sustainable solution for some of the issues associated with suspension formulations in the respiratory device industry.

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

Cormac O’Prey discusses some of the sustainability challenges facing the medical sector, such as how to make re-use and remanufacturing viable for high-volume, low-value products, and how answers can be found by looking to successful solutions deployed by other industries.

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Phillips-Medisize

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Emil Fraenkel and Bjarne Sørensen consider the sustainability of re-usable and disposable autoinjectors, its implications in adding connectivity to drug delivery devices and how it has been an important consideration for Phillips-Medisize in the development of the Aria re-usable autoinjector.

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

Pharmapack presents the results of its annual survey and market report, covering the latest Pharmapack Innovation Index and the inaugural Pharmapack Sustainability Index, and taking stock of where the survey results suggest the pharma industry currently is, and where it is heading, in terms of innovation and sustainability.

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell discusses the major factors at play driving the direction of innovation in the subcutaneous drug delivery space, with a particular emphasis on the push towards patient self-administration.

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Mr Michael Kiely

Jabil Healthcare

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Michael Kiely, Gerard Linnane and Justin Carroll discuss how implementing a thoughtful design-for-sustainability process can ensure medical devices not only improve patients’ lives but are also kinder to the environment.

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

Charlie Dean, Kay Sinclair and Brennan Miles provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.

CREATING TIMELESS DEVICE TECHNOLOGIES

CREATING TIMELESS DEVICE TECHNOLOGIES

Andrew Moore and Gene Rhode Fuensalida Pantig discuss the importance of a sound strategy for product lifecycle management.

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

Mathias Romacker

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.

RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS

INDUSTRIALISATION

William Jaworski

Mikron Automation

RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS

William Jaworski and Michael Gunner discuss the precision and complex manipulation of needles required for the latest combination medical products.

FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS

Carsten Köhler

FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS

Carsten Köhler, Umit Ismail Tsavous and Gerd Vosshage explain the company’s processes for the automated assembly and testing of pen and autoinjectors.

CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY

CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY

Michael Roe discusses the development of the Aerio™ Platform of gas-powered injection systems.

THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER

Pfizer CentreOne

THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER

Jennifer Quint offers insights into how to plan and execute technology transfer effectively, explaining Pfizer CentreOne’s three-phased approach that can successfully support this pivotal event in a drug product programme’s journey to commercialisation.

PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions

INDUSTRIALISATION

Wolfgang Moersch

PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions

ZwickRoell showcases its comprehensive automated testing solutions.

UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS

UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS

Richard Motruk and Nathan Blazei discuss the issues to be considered in light of the US FDA’s tightened reliability standards for emergency-use autoinjectors.

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Dr Kate Hudson-Farmer

Phillips-Medisize

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.

GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES

PREFILLED SYRINGES

Dr Wenzel Novak

GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES

Wenzel Novak and Stefan Verheyden introduce Gx InnoSafe, a novel integrated passive needle safety system for preventing needlestick injuries and accidental reuse of syringes that minimises additional burden on healthcare workers during injection and can be integrated into existing pharmaceutical filling operations without the need for adaptation or conversion of processing lines.

A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT

Asmita Khanolkar

A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT

Asmita Khanolkar outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery.

INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI

INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI

Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how the acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies, providing additional services to progress combination products to market.

PHOTOSTABILITY TESTS OF ANTIBODY DRUGS

PREFILLED SYRINGES

Mitsubishi Gas Chemical

PHOTOSTABILITY TESTS OF ANTIBODY DRUGS

Yoshiko Sakuma and Tomohiro Suzuki provide an overview of Mitsubishi Gas Chemical's OXYCAPT multilayer vial and syringe, with a particular focus on the recent investigations into the interaction of OXYCAPT’s UV barrier with the photostability of antibody drugs, compared with standard cyclo-olefin polymer and Type 1 glass.

YPSODOSE – SIMPLIFYING LARGE-VOLUME PATCH INJECTIONS

YPSODOSE – SIMPLIFYING LARGE-VOLUME PATCH INJECTIONS

Ian Thompson provides the latest insights into the YpsoDose prefilled and pre-assembled patch injector as it moves into the industrialisation phase for clinical trials.

DESIGNING DRUG DELIVERY DEVICES THROUGH COLLABORATIVE USABILITY TESTING

DESIGNING DRUG DELIVERY DEVICES THROUGH COLLABORATIVE USABILITY TESTING

Alice Bogrash examines how the company uses human factors studies to design drug delivery devices that respond to user needs, while providing a competitive advantage for pharmaceutical companies looking to introduce innovative combination products to the market.

1
2
3
…
28
Next

See what ondrugdelivery's readers and contributors think

Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Top